Goldman Sachs Group Inc Re Shape Lifesciences Inc. Transaction History

Goldman Sachs Group Inc

  • $706 Billion
  • Q2 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

May 14, 2024
BUY
$0.32 - $15.6 $4,589 - $223,750
14,343 New
14,343 $4,000
Q3 2022

Nov 10, 2022
BUY
$0.32 - $15.6 $4,589 - $223,750
14,343 New
14,343 $0

About ReShape Lifesciences Inc.

RSLS Quotes by TradingView
  • Ticker RSLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,559,400
  • Market Cap $354M
  • Description
  • ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical sta...
More about RSLS
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email